Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Diseases

Explore clinical trials studying Urinary Bladder Diseases. Study availability and eligibility vary by location and protocol.

2,285 public trials 413 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Diseases trial results

Active, Not Recruiting

Atezolizumab After Chemo-radiotherapy for MIBC Patients Not Eligible for Radical Cystectomy

NCT03697850

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Institut Bergonie Bordeaux, France
  • Centre Jean Perrin Clermont-Ferrand, France
  • Centre Georges Francois Leclerc Dijon, France
  • Centre Oscar Lambret Lille, France
View Trial Details
Active, Not Recruiting

Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

NCT04180371

Conditions
Adnexal Diseases, Advanced Solid Tumor Historically Known for High EphA2 Expression, Breast Diseases, +49 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. Encinitas, California, United States
  • University of California - Irvine Medical Center Orange, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

NCT04561362

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Diseases, +30 more
Locations
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Ocala Oncology Center Ocala, Florida, United States
  • Advent Health Orlando, Florida, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer

NCT03022825

Conditions
Bladder Cancer, Carcinoma, Female Urogenital Diseases, +13 more
Locations
  • Alaska Clinical Research Center Anchorage, Alaska, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • UCLA Department of Urology Los Angeles, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors

NCT05393427

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
  • West China Hospital, Sichuan University Chengdu, Sichuan, China
View Trial Details

Related conditions